Vitamin D2 Supplements May Reduce D3 Levels, Raising Questions About Supplement Effectiveness

The Unexpected D2-D3 Interaction

Recent research has uncovered a counterintuitive finding: taking vitamin D2 supplements can actually lower levels of vitamin D3 in the body. A 2025 meta-analysis published in Nutrition Reviews examined 20 randomized controlled trials and found that people taking vitamin D2 had significantly lower concentrations of 25-hydroxyvitamin D3—the form doctors measure in blood tests to assess vitamin D status—compared to those who did not take D2. Depending on analytical methods, the average reduction ranged from roughly 9 to 18 nanomoles per liter. This represents a previously unknown biological effect that challenges the assumption that the two forms are metabolically interchangeable.

Why D2 and D3 Matter Differently

Vitamin D2, or ergocalciferol, is typically manufactured from fungi or yeast exposed to ultraviolet light and has been widely used in supplements and food fortification. Vitamin D3, or cholecalciferol, is the form naturally produced by human skin when exposed to sunlight. While traditional supplements often used lanolin from sheep's wool as a D3 source, plant-based alternatives derived from lichen are now available. The distinction matters because research consistently shows that vitamin D3 is more effective at raising and maintaining circulating vitamin D levels than D2. Current guidance from the U.S. National Institutes of Health reflects this evidence, noting that D3 produces larger increases and sustains elevated levels longer than D2.

The Mechanism Remains Unclear

Scientists do not yet fully understand why vitamin D2 reduces vitamin D3 levels. One leading hypothesis involves the body's homeostatic regulation of vitamin D metabolites. When vitamin D concentrations rise, the body may accelerate the breakdown and removal of existing compounds to maintain balance—a process that could inadvertently increase the disposal of existing 25-hydroxyvitamin D3 when D2 is introduced. Some evidence suggests this relationship may work bidirectionally, with D3 supplementation sometimes reducing D2-derived metabolites. However, researchers emphasize that D2 reducing D3 does not mean D2 simply removes vitamin D from the body or that taking it is inherently harmful. D2 still raises its own metabolite form and contributes to total vitamin D status.

Divergent Immune System Effects

Beyond their differing effects on circulating D3, research suggests D2 and D3 may have distinct biological actions. A study published in Frontiers in Immunology examined how each form affected gene activity in blood cells and discovered substantial differences in immune system responses. Vitamin D3 appeared to stimulate type I interferon signaling—a critical early-defense mechanism against viral and bacterial infections—while vitamin D2 did not produce this effect. Type I interferons are signaling proteins that alert cells to developing infections and form a foundational part of immune defense. This finding suggests that vitamin D3 may offer immunological advantages beyond simple vitamin D status elevation, though researchers caution that changes in gene activity do not necessarily translate directly into fewer infections, and larger clinical trials are needed to establish practical health implications.

Important Caveats and Lingering Questions

A 2026 systematic review and meta-analysis of 26 randomized trials provided important context by showing that D2 supplementation significantly reduced parathyroid hormone levels and produced small increases in blood calcium, demonstrating that D2 continues to have meaningful biological effects despite lowering circulating D3. This finding underscores that the reduction in D3 should not be misinterpreted as evidence that D2 is ineffective. The accumulated evidence from multiple meta-analyses shows that D3 is more effective at improving overall vitamin D status, but both forms can contribute meaningfully to vitamin D levels. The central unresolved question is whether the biochemical differences between D2 and D3—particularly the D2-induced reduction in D3 and the divergent immune effects—translate into clinically meaningful differences in long-term health outcomes.

Current Recommendations and Future Directions

For now, the evidence increasingly points toward vitamin D3 as the preferred supplement form, particularly given that plant-based versions are becoming more accessible in the market. The UK recommends considering 10 micrograms of vitamin D daily during darker months when sunlight is insufficient for skin synthesis. Researchers emphasize that additional studies are needed to clarify D2 and D3 metabolism, confirm whether their immune effects produce measurable health differences, and establish whether D3 should become the standard for routine supplementation absent specific individual reasons to use D2. The findings highlight that supplement labels matter and that treating D2 and D3 as fully equivalent represents an oversimplification of their metabolic roles.